1020 Kifer Rd
Sunnyvale, California 94086-5301
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. In the quarter ended June 30, 2022, Baron Health Care Fund (the “Fund”) declined 10.00% (Institutional Shares), compared with the 7.43% decline for the Russell 3000 Health Care Index (the […]
Related Stocks: SNOW , PYPL , CTLT , ISRG , PH ,
Related Stocks: AAPL , IWM , GOOGL , PSTG , ISRG ,
Related Stocks: PLD , ISRG , AEP , STZ , ROK ,
Believe it or not, the health care sector is actually one of the better performers in 2022, with medical device makers Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) outperforming the broader sector in the past month. The Health Care Select Sector SPDR ETF NYSEARCA:XLV) is down 6.48% year-to-date. Here are the biggest sector components and their […]
Related Stocks: NVDA , ISRG , ATVI , MA , TTD ,
Related Stocks: SGEN , VRTX , MCK , MDT , ISRG ,
Related Stocks: ELAN , ADBE , ISRG , SBUX , AMZN ,
Intuitive Surgical Inc. (NASDAQ:ISRG) price is hovering higher on Wednesday, July 27, jumping 2.52% above its previous close. A look at today’s price movement shows that the recent level at last check reads $216.79, with intraday deals fluctuating between $214.08 and $219.92. The company’s 5Y monthly beta was ticking 1.17 while its P/E ratio in … How Do Things Look For Intuitive Surgical Inc. (NASDAQ: ISRG) In The Short-Term? Read More »
Second-quarter 2022 financial results weren''t as good as expected -- but were still solid.
With fears of a global recession rising, it’s natural that investors have turned their back on growth-intensive names. However, this backdrop has also yielded compelling undervalued biotech stocks to buy. While very few sectors have been spared the damage stemming from soaring inflation, geopolitical instability and supply chain disruptions, the biological sciences arena offers long-term relevance. Mainly, it doesn’t matter whether a recession is about to capsize our economy or not. Since humans remain vulnerable to various diseases and medical conditions, it’s imperative that researchers continue to move forward. Therefore, undervalued biotech stocks to buy command significant interest because at some point, they have the potential to rise substantially higher. The 7 Best Funds For Retirees To be fair, the underlying sector is volatile. And many times, a company sheds basis points in the equities market for a reason — often not a good one. Still, if you have some spare funds for speculation, these undervalued stocks to buy could offer significant bang for your buck.
Shares of Intuitive Surgical (NASDAQ: ISRG) were down 5.7% to close at $211.85 on Friday following the company’s disappointing Q2 results. Intuitive Surgical is headquartered in Sunnyvale, California, and is a developer, manufacturer, and marketer of the da Vinci surgical system. This surgical system helps doctors conduct minimally invasive, robotic-assisted surgery. However, BTIG analyst Ryan Zimmerman remained upbeat about the stock with a Buy rating. Intuitive Surgical’s Q2 Results In the second quarter, ISRG generated revenues of $1.52 billion, up 4% year-over-year but missing analysts’ estimates by $38.4 million. The company’s adjusted net income also declined to $1.14 per diluted share versus $1.
This leader''s woes won''t last forever.
Intuitive missed on the top and bottom lines, and its stock is expensive.
Yesterday, Intuitive Surgical Inc (NASDAQ: ISRG ) reported lower-than-expected Q2 earnings . Raymond James writes, "we were worried about the capital equipment environment, we admittedly did not think ISRG''s 2Q print would be the ''event'' that fully triggered the concern." The analysts believe slowing replacement cycle, supply chain issues, and constrained U.S. hospital budgets will temper system placements, thus driving an estimate reset. The absence of Systems guidance, the uncertainty around the duration of the capital equipment slowdown, and the lack of visibility into the timing of … Full story available on Benzinga.com
Source: Bukhta Yurii / Shutterstock.com VistaGen Therapeutics (NASDAQ: VTGN ) stock is falling hard on Friday after the clinical-stage biopharmaceutical company reported poor results from a Phase 3 study . That clinical trial covers PH94B as a treatment for anxiety in adults with social anxiety disorder. The bad news is that PH94B failed to meet the primary endpoint of the clinical trial. That means it failed to cause a significant change from baseline on the Subjective Units of Distress Scale when compared to a placebo. Despite the poor results from the Phase 3 clinical trial, VistaGen Therapeutics isn’t giving up on PH94B just yet. The company intends to continue the ongoing PALISADE-2 Phase 3 trial and Phase 2 trial in adjustment disorder with anxiety. 7 Best Reddit Stocks to Buy Now Shawn Singh, CEO of VistaGen Therapeutics, said the following about the clinical trial results. “The demand for new treatment options for anxiety disorders is large and growing. While the results of PALISADE-1 are not consistent with prior positive results from Phase 2 trials of PH94B in social anxiety disorder, we remain committed to transforming the treatment landscape for those living with anxiety, depression, and other central nervous system disorders.” It’s worth pointing out that PH94B is one of three drug candidates in the company’s pipeline.
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Brian King — Treasurer and Head of Investor Relations Gary S. Guthart — Chief Executive Officer and Member of […] The post Intuitive Surgical, Inc. (ISRG) Q2 2022 Earnings Call Transcript first appeared on AlphaStreet .
Snap Inc. (NYSE: SNAP ) fell 28.4% to $11.70 in pre-market trading after the company reported worse-than-expected Q2 results, announced a reduction in the hiring rate and did not provide guidance. Intuitive Surgical, Inc. (NASDAQ: ISRG ) shares fell 11.9% to $198.00 in pre-market trading after the company reported second-quarter revenue growth of 4% year-over-year to $1.52 billion, +6% on a constant currency basis, missing the consensus of $1.56 billion. SVB Financial Group (NASDAQ: SIVB ) fell 11.7% … Full story available on Benzinga.com
The post Dow Jones Futures Fall: Snap Crash Hits Online Giants After Tesla Drives Market Rally Higher appeared on BitcoinEthereumNews.com . Dow Jones futures fell modestly early Friday, along with S&P 500 futures and Nasdaq futures, as Intuitive Surgical and especially Snap weighed on several online giants. The stock market rallied,…
Intuitive Surgical, Inc. (NASDAQ:NASDAQ:ISRG) Q2 2022 Earnings Conference Call July 21, 2022 4:30 PM ET Company Participants Brian King – Head-Investor Relations Gary Guthart – Chief…
Intuitive Surgical (ISRG) is scheduled to announce Q2 earnings results on Thursday, July 21st, after market close.The consensus EPS Estimate is $1.20 (-69.4% Y/Y) and the consensus…
Intuitive Surgical (NASDAQ: ISRG ) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here''s what investors need to know before the announcement. Analysts estimate that Intuitive Surgical will report an earnings per share (EPS) of $1.19. Intuitive Surgical bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com
Related Stocks: SDS , AXP , MCD , ADBE , ISRG ,
While several investors are spooked by the fear of a looming recession, there are some who are looking for stocks with strong fundamentals at attractive price points. Generally, healthcare companies are considered to be more resilient in an economic downturn, compared to companies in certain other sectors. However, investors need to check company-specific risks before buying any stock. Amid this backdrop, we used the TipRanks Stock Comparison Tool to place CVS Health, Teladoc, and Intuitive Surgical against each other, to pick the healthcare stock that could yield better returns.
This medical device stock is one to watch.
Intuitive Surgical (NASDAQ: ISRG ) has outperformed the market over the past 20 years by 20.75% on an annualized basis producing an average annual return of 28.79%. Currently, Intuitive Surgical has a market capitalization of $72.38 billion. Buying $1000 In ISRG: If … Full story available on Benzinga.com
Related Stocks: MRK , ISRG , MCK , ZTS , AMZN ,
Intuitive Surgical is a clear leader in the robotic surgery market with technological superiority and large switching costs.
Shares of Intuitive Surgical have seen a real pullback. While ISRG stock looks compelling, check out why I believe for real appeal further setbacks are required.
A whale with a lot of money to spend has taken a noticeably bullish stance on Intuitive Surgical . Looking at options history for Intuitive Surgical (NASDAQ: ISRG ) we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and 45% with bearish. From the overall spotted trades, 9 are puts, for a total amount of $583,802 and 2, calls, for a total amount of $222,750. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $205.0 to $220.0 for … Full story available on Benzinga.com
Its stock is looking quite affordable compared to last year.
If you’re looking to make gains in a bear market, then you need to find the right growth stocks to buy. Intuitive Surgical ( ISRG ): Flagship da Vinci systems continue to gain traction with every passing quarter. Teladoc Health ( TDOC ): Membership base continues to rise at an aggressive pace despite the pandemic fade. CrowdStrike Holdings ( CRWD ): Recurring revenues and retention rates remain impressive and will continue driving robust growth. Globant SA ( GLOB ): Has a massive client base who are likely to consume its new services. Fiverr International ( FVRR ): Total active buyers are rising at a brisk pace and the addition of new features adds to the stickiness of the platform. Snap ( SNAP ): Ads business continues to take its cash flows to new heights. Boot Barn ( BOOT ): Strategic efforts are driving sales through its vast brands portfolio. Source: Freedom365day / Shutterstock.com Investing in a bear market is typically a tricky proposition. Plenty of stocks are trading at attractive valuations, but selecting the best ones for the long haul can be daunting.
Growth stocks feature companies with stock prices that have been increasing steadily over a while. In turn, the stocks are usually purchased by investors who wish to profit from the company’s expected growth. However, growth stocks have not done well recently. Nonetheless, the biggest reason we can point to is because of increasing inflation . The prices of food and energy are both rising in a widespread manner around the world, and it’s been primarily driven by post-pandemic demand and the Russian invasion of Ukraine . Overall, this rise in inflation is a worldwide trend that you’ll want to monitor closely. With all of this in mind, many investors are hesitant to invest in growth stocks because of the recent bear market and drop in stock prices. But these opportunities do exist for those who can find them. There is a huge opportunity for investors to purchase excellent growth stocks at a steep discount. 7 Bargain Income Stocks to Buy and Hold Forever So, let’s dive in and take a closer look at seven growth stocks for you to keep your eye on.
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for minimally invasive surgery, help healthcare professionals conduct procedures with high precision while significantly reducing the recovery time for patients. Since the company''s devices are made mainly for elective surgeries, sales were affected during […]
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for minimally invasive surgery, help healthcare professionals conduct procedures […] The post Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown first appeared on AlphaStreet .